January 28, 2023

CDC clears the way for Pfizer COVID vaccine for kids 5 to 11

U.S. health officials on Tuesday gave the final signoff to Pfizer’s kid-size COVID-19 shot, a milestone that opens a major expansion of the nation’s vaccination campaign to children as young as 5.

The Food and Drug Administration already authorized the shots for children ages 5 to 11 — doses just a third of the amount given to teens and adults. But the Centers for Disease Control and Prevention formally recommends who should receive FDA-cleared vaccines.

The announcement by CDC director Dr. Rochelle Walensky came only hours after an advisory panel unanimously decided Pfizer’s shots should be opened to the 28 million youngsters in that age group.

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.

“As a mom, I encourage parents with questions to talk to their pediatrician, school nurse or local pharmacist to learn more about the vaccine and the importance of getting their children vaccinated,” Walensky said Tuesday night, in a statement.

In remarks earlier in the day, she said while the risk of severe disease and death is lower in young children than adults, it is real — and that COVID-19 has had a profound social, mental health and educational impact on youngsters, including widening disparities in learning.

“There are children in the second grade who have never experienced a normal school year,” Walensky said. “Pediatric vaccination has the power to help us change all of that.”

President Joe Biden called the decision “a turning point.”

“It will allow parents to end months of anxious worrying about their kids, and reduce the extent to which children spread the virus to others,” he said in a statement. “It is a major step forward for our nation in our fight to defeat the virus.”

The American Academy of Pediatrics welcomed the decision as its members get ready to start the first injections into little arms, which the CDC said could begin “as soon as possible.” The 5- to 11-year-olds will receive two low doses, three weeks apart, of the vaccine made by Pfizer and its partner BioNTech — the same schedule as everyone else, but using a smaller needle.

Pfizer over the weekend began shipping millions of the pediatric shots to states, doctors’ offices and pharmacies — in orange caps, to avoid mix-ups with purple-capped vials of adult vaccine.

Many parents have clamored for vaccine protection for youngsters so they can resume normal childhood activities without risking their own health — or fear bringing the virus home to a more vulnerable family member. But CDC’s advisers said they recognize many parents also have questions, and may be fearful of the vaccine because of rampant misinformation.

Members of the advisory panel said they want parents to ask about the shots — and understand that they’re far better than gambling that their child will escape a serious coronavirus infection. As for safety, more than 106 million Americans have safely gotten two doses of Pfizer’s full-strength shots — including more than 7 million 12- to 15-year-olds.

WATCH: CDC says the definition of ‘fully vaccinated’ may change as more people get boosters

“I have vaccinated my kids,” said CDC adviser Dr. Helen Keipp Talbot of Vanderbilt University, saying she wouldn’t recommend something for other families unless she was comfortable with it for her own. “We have seen the devastation of this disease.”

In the U.S., there have been more than 8,300 coronavirus-related hospitalizations of kids ages 5 to 11, about a third requiring intensive care, according to government data. The CDC has recorded at least 94 deaths in that age group, with additional reports under investigation.

And while the U.S. has seen a recent downturn in COVID-19 cases, experts are worried about another uptick with holiday travel and as winter sends more activity indoors where it’s easier for the coronavirus to spread.

READ MORE: CDC expands booster rollout, OKs mixing shots

Pfizer’s study of 2,268 youngsters found the kid-size vaccine is nearly 91% effective at preventing symptomatic COVID-19 — based on 16 diagnoses among kids given dummy shots compared to just three who got the real vaccination.

READ MORE: CDC advisers endorse COVID shot for kids 5-11

The FDA examined more children, a total of 3,100 who were vaccinated, in concluding the shots are safe. The younger children experienced similar or fewer reactions — such as sore arms, fever or achiness — than teens or young adults get after larger doses.

That study wasn’t large enough to detect any extremely rare side effects, such as the heart inflammation that occasionally occurs after the second full-strength dose, mostly in young men and teen boys. Regulators ultimately decided the benefits from vaccination outweigh the potential that younger kids getting a smaller dose also might experience that rare risk.

Some of CDC’s advisers said for some parents, deciding to get their children vaccinated may hinge on that small but scary risk.

“The risk of some sort of bad heart involvement is much higher if you get COVID than if you get this vaccine,” Dr. Matthew Oster, a pediatric cardiologist at Emory University, told the panel. “COVID is much riskier to the heart.”

Last week, FDA’s advisers struggled with whether every young child needed a vaccine. Youngsters hospitalized with COVID-19 are more likely to have high-risk conditions such as obesity or diabetes. But otherwise healthy children can get seriously ill, too, and the CDC’s advisers ultimately recommended the shots for all of them — even children who’ve already recovered from a bout of COVID-19.

CDC officials calculated that for every 500,000 youngsters vaccinated, between 18,000 and 58,000 COVID-19 cases — and between 80 and 226 hospitalizations — in that age group would be prevented, depending on the pandemic’s trajectory. And CDC officials noted that COVID-19 has caused more deaths in this age group than some other diseases, such as chickenpox, did before children were routinely vaccinated against them.

What about younger children? Pfizer is testing shots for babies and preschoolers and expects data around the end of the year. The similarly made Moderna vaccine also is being studied with young children. But the FDA still hasn’t cleared its use in teens, and the company is delaying its application for younger children pending that review.

A few countries have begun using other COVID-19 vaccines in children under 12, including China, which just began vaccinations for 3-year-olds. But many that use the Pfizer-BioNTech vaccine are watching the U.S. decision, and European regulators just began considering the companies’ kid-size doses.

in Health
Related Posts

After 40 years of AIDS, progress has been made but major problems remain

June 10, 2021

June 10, 2021

William Brangham: In the 1980s and early ’90s, the AIDS epidemic was marked by two kinds of images. One, we...

Hundreds of bodies found buried along Indian riverbanks

May 16, 2021

May 16, 2021

PRAYAGRAJ, India — Police are reaching out to villagers in northern India to investigate the recovery of bodies buried in...

Spears set to make rare remarks to conservatorship judge

June 23, 2021

June 23, 2021

LOS ANGELES — In the most anticipated hearing in the case in years, Britney Spears is expected to address a...

UK’s Heathrow Airport opens terminal for high-risk travelers

June 1, 2021

June 1, 2021

LONDON (AP) — A terminal at London’s Heathrow Airport that was mothballed because of the coronavirus pandemic reopened Tuesday to...

A Brief But Spectacular take on breaking the script in healthcare

June 7, 2021

June 7, 2021

Judy Woodruff: Carey Candrian is a Colorado-based social scientist. She’s spent much of her career investigating how health care can...

Vaccinations are picking up. Is it time to reopen the US-Canada border?

May 15, 2021

May 15, 2021

Benedict Moran: Now, despite the border closure, infection rates in Canada are higher than the US. And the country has...

Science chief wants next pandemic vaccine ready in 100 days

June 2, 2021

June 2, 2021

The new White House science adviser wants to have a vaccine ready to fight the next pandemic in just about...

12 lessons COVID-19 taught us about developing vaccines during a pandemic

July 2, 2021

July 2, 2021

The extraordinary drive to develop COVID-19 vaccines was like a moonshot — and like that fabled acceleration of space exploration...

WATCH LIVE: How to take care of your mental health as the world returns to ‘normal’

May 28, 2021

May 28, 2021

Many Americans are facing mental health challenges as they deal with the tumult of the last year and the uncertainties...

40 years on, HIV/AIDS is still spreading despite medical advancement

June 5, 2021

June 5, 2021

Chris Beyrer: Yeah, yeah. Well, I lost my first partner to HIV before there was any treatment. He was a...

J&J agrees to pay $230M to settle New York opioid claim

June 26, 2021

June 26, 2021

NEW YORK — The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle...

G-7 nations gather to pledge 1 billion vaccine doses for world

June 11, 2021

June 11, 2021

CARBIS BAY, England (AP) — Leaders from the Group of Seven industrialized nations are set to commit at their summit...

U.S. officials extend expiration dates on Johnson & Johnson vaccine doses

June 10, 2021

June 10, 2021

WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of...

Watchdog says almost 900 Secret Service employees were infected with COVID

June 22, 2021

June 22, 2021

WASHINGTON (AP) — Roughly 900 U.S. Secret Service employees tested positive for the coronavirus, according to government records obtained by...

Only Michigan employee fired over Flint water to be paid $300K

November 5, 2021

November 5, 2021

DETROIT (AP) — The state of Michigan said Friday it agreed pay $300,000 to settle wrongful discharge claims by the...